Rimegepant for the treatment of migraine
Migraine is a common form of primary headache, affecting up to 1 in every 6 Americans. The pathophysiology is an intricate interplay of genetic factors and environmental influence and is still being elucidated in ongoing studies. The trigeminovascular system is now known to have a significant role i...
Saved in:
Main Authors: | Amnon A. Berger, Ariel Winnick, Austin H. Carroll, Alexandra Welschmeyer, Nathan Li, Marc Colon, Antonella Paladini, Giovanni F. Ramírez, Jamal Hasoon, Elyse M. Cornett, Jaehong Song, Giustino Varrassi, Adam M. Kaye, Alan D. Kaye, Latha Ganti |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-10-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.38534 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of Interventional Therapies for Refractory Pediatric Migraine
by: Jacquelin Peck, et al.
Published: (2023-01-01) -
Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults
by: Amnon A. Berger, et al.
Published: (2022-11-01) -
Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
by: Elyse M. Cornett, et al.
Published: (2022-10-01) -
A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine
by: Nazir Noor, et al.
Published: (2022-04-01) -
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes
by: Amnon A. Berger, et al.
Published: (2022-06-01)